These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7797578)
21. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites. Li J; Cook R; Dede K; Chaiken I J Biol Chem; 1996 Jan; 271(4):1817-20. PubMed ID: 8567620 [TBL] [Abstract][Full Text] [Related]
22. Cytokine recognition by human interleukin 5 receptor. Ishino T; Robertson N; Chaiken I Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273 [TBL] [Abstract][Full Text] [Related]
23. Interaction of GM-CSF and IL-3 with the common beta-chain of their receptors. Bagley CJ; Woodcock JM; Hercus TR; Shannon MF; Lopez AF J Leukoc Biol; 1995 May; 57(5):739-46. PubMed ID: 7759954 [TBL] [Abstract][Full Text] [Related]
24. Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. Lock P; Metcalf D; Nicola NA Proc Natl Acad Sci U S A; 1994 Jan; 91(1):252-6. PubMed ID: 8278375 [TBL] [Abstract][Full Text] [Related]
25. Defining the regions of human interleukin-5 important in receptor binding and cellular activation. Wells TN; Graber P; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Proudfoot AE Ann N Y Acad Sci; 1996 Oct; 796():226-34. PubMed ID: 8906230 [No Abstract] [Full Text] [Related]
26. Signaling domains of the beta c chain of the GM-CSF/IL-3/IL-5 receptor. Okuda K; Foster R; Griffin JD Ann N Y Acad Sci; 1999 Apr; 872():305-12; discussion 312-3. PubMed ID: 10372132 [TBL] [Abstract][Full Text] [Related]
27. Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation. Ishino T; Pillalamarri U; Panarello D; Bhattacharya M; Urbina C; Horvat S; Sarkhel S; Jameson B; Chaiken I Biochemistry; 2006 Jan; 45(4):1106-15. PubMed ID: 16430207 [TBL] [Abstract][Full Text] [Related]
28. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene. van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor. Shiiba M; Takaki S; Takatsu K Int Arch Allergy Immunol; 1996; 111 Suppl 1():12-5. PubMed ID: 8906104 [TBL] [Abstract][Full Text] [Related]
30. [Characterization of a receptor for interleukin-5 on pulmonary eosinophils with eosinophilic pneumonia]. Chihara J; Nakajima S Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():70-6. PubMed ID: 1306241 [TBL] [Abstract][Full Text] [Related]
31. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5. Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609 [TBL] [Abstract][Full Text] [Related]
32. Structure-function analysis of the C-terminal segment of human interleukin-6. Li X; Rock F; Chong P; Cockle S; Keating A; Ziltener H; Klein M J Biol Chem; 1993 Oct; 268(30):22377-84. PubMed ID: 7693665 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains. Murphy JM; Ford SC; Olsen JE; Gustin SE; Jeffrey PD; Ollis DL; Young IG J Biol Chem; 2004 Jun; 279(25):26500-8. PubMed ID: 15060062 [TBL] [Abstract][Full Text] [Related]
34. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition. Morton T; Li J; Cook R; Chaiken I Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10879-83. PubMed ID: 7479902 [TBL] [Abstract][Full Text] [Related]
35. Randomization of the receptor alpha chain recruitment epitope reveals a functional interleukin-5 with charge depletion in the CD loop. Wu SJ; Li J; Tsui P; Cook R; Zhang W; Hu Y; Canziani G; Chaiken I J Biol Chem; 1999 Jul; 274(29):20479-88. PubMed ID: 10400676 [TBL] [Abstract][Full Text] [Related]
37. Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5. Devos R; Guisez Y; Plaetinck G; Cornelis S; Tavernier J; van der Heyden J; Foley LH; Scheffler JE Eur J Biochem; 1994 Oct; 225(2):635-40. PubMed ID: 7957178 [TBL] [Abstract][Full Text] [Related]
38. The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization. Proudfoot AE; Brown SC; Graber P; Talabot F; Arod CY; Peitsch MC; Banks M; McKinnon M; Solari R; Wells TN J Protein Chem; 1996 Jul; 15(5):491-9. PubMed ID: 8895095 [TBL] [Abstract][Full Text] [Related]
39. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Guthridge MA; Stomski FC; Thomas D; Woodcock JM; Bagley CJ; Berndt MC; Lopez AF Stem Cells; 1998; 16(5):301-13. PubMed ID: 9766809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]